Hard to believe?, page-94

At times like this, I find it best to focus on the science. The market has a way of fearing you out of a stock. Let the tree shake...it did it last year around this time down to 1.2cents and then bang...3 months later 4 cents.
The full phase 1b Data is to be presented in the first week of April and to me it looks pretty impressive data.
The deals in imunoncology look to be getting bigger and bigger. Axels deal last week is testament to the size of the “Deal” Pharma are willing to do for science with good data. My bet is there is going to be plenty of interest from Pharma in this data...maybe Glaxo and maybe Roche...who knows but it’s firming up I reckon.